Autonomix Medical, Inc. AMIX
Set alert
At close · Oct 30
After hours · Oct 30, 7:43 PM ET
- YTD
- -84.33%
- 1 year
- -91.63%
- Open
- 2.08
- Prev close
- 2.06
- Mkt cap
- 3.55M
- Vol
- 135.41K
- Avg vol
- 3.03M
- EPS
- -39.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.81
- High
- 2.15
- Forward P/E
- -0.46
- Beta
- 0.00
- Short ratio
- 0.06
- Inst. own
- 17.72%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.29
- 200-d avg
- 26.81
- 1y target
- 28.00
MAX chart
Events in this range
- Sep 3, 2024Rating: Ladenburg Thalmann · — → Buy
- Oct 25, 2024Split: 1 for 20
- Jun 24, 2026Split: 1 for 21
Signals (29)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| RSI: Oversold | Jul 13, 2026 | 3 months ago |
| RSI: Oversold | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| RSI: Oversold | May 4, 2026 | 6 months ago |
| RSI: Oversold | Apr 6, 2026 | 6 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| RSI: Oversold | Mar 9, 2026 | 7 months ago |
| RSI: Oversold | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| RSI: Oversold | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| RSI: Oversold | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| RSI: Oversold | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Apr 29, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
Key statistics
- Market cap
- 5.99M
- Enterprise value
- 78.74K
- Trailing P/E
- 0.00
- Forward P/E
- -0.46
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.06
- EPS (TTM)
- -19.74
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -5.49M
- Total cash
- 5.16M
- Total debt
- 1.09M
- Return on equity
- -27017.08%
- Shares outstanding
- 1.77M
- Short % of float
- 2.85%
- 50-day average
- 8.29
- 200-day average
- 26.81
Analyst view
Consensus: none
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 3, 2024 | Ladenburg Thalmann | init | — | Buy |
About Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- autonomix.com
News
- Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
- Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform
- Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
- Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye
- Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
- Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
- Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
- Autonomix Medical Announces Issuance Of U.S. Patent Titled 'Systems And Methods For Regulating Organ And/Or Tumor Growth Rates, Function, And/Or Development' On August 25
- Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Your note
Sign in to keep a note on AMIX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Mariner, LLC | 0.49% | 5,619 | 19.05K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.39% | 4,481 | 15.19K | Sep 29, 2024 |
| HRT Financial LP | 0.26% | 3,053 | 10.35K | Sep 29, 2024 |
| PNC Financial Services Group, Inc. | 0.16% | 1,837 | 6.23K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.10% | 1,184 | 4.01K | Sep 29, 2024 |
| Virtu Financial LLC | 0.07% | 756 | 2.56K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.29% | 3,296 | 11.17K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.14% | 1,589 | 5.39K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.09% | 1,035 | 3.51K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.07% | 776 | 2.63K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 347 | 1.18K | Oct 30, 2024 |
| EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 160 | 542 | Sep 29, 2024 |